Ram Aderet Follow-up: Why the Bank Waiver Matters More Than the Relative Calm in the Bonds
At year-end 2025 Ram Aderet’s bonds were still inside their covenant package, but the remaining bank commitment had already broken and needed a waiver through the March 31, 2026 statements. That matters more because the bridges to permits and real cash release still sit with banks and institutional lenders.
What This Follow-up Is Isolating
The main article argued that Ram Aderet was still funding growth until project surpluses began turning into accessible cash. This follow-up isolates where that argument becomes especially sharp at year-end 2025: the gap between the bond layer, which still looks acceptable on covenants, and the bank and institutional credit layer, which already needed waivers and extensions.
That gap is easy to miss precisely because Ram Aderet is a bonds-only listed issuer. The public lens naturally goes straight to Series B, C and D. But in the annual package, the tighter signal does not come from there. It comes from the one remaining bank commitment that still carried the old covenant package, and from the need to keep rolling land financing until permits turn into full project financing.
The February 2026 investor presentation points in the same direction. On the September 30, 2025 balance sheet, bank and other credit stood at about NIS 555.5 million, against roughly NIS 243.9 million of current and non-current bonds and about NIS 186.4 million of equity. So even before year-end, the real financing center of gravity already sat outside the bond layer.
Where The Bank Actually Broke
Note 15 tells a very uneven story. The company had committed to three banks to maintain accounting equity of at least NIS 185 million and an equity-to-net-balance ratio of at least 17%. During the period it signed amended commitment letters with two of the three banks, eliminating those financial covenants. The one commitment that remained unchanged is the one where the company was no longer in compliance.
The numbers leave little room for interpretation. As of December 31, 2025, equity stood at about NIS 181.2 million and the equity-to-net-balance ratio stood at 15.5%. In other words, the company was below the remaining bank thresholds on both the absolute equity test and the ratio test. That is why it needed a waiver for the December 31, 2025 and March 31, 2026 financial statements.
| Metric | Year-end 2025 | Remaining bank threshold | Bond thresholds | The right read |
|---|---|---|---|---|
| Equity | About NIS 181.2 million | At least NIS 185 million | At least NIS 130 million, with coupon step-up thresholds at NIS 140 million for Series B and C and NIS 155 million for Series D | Broken versus the bank, still above the bond package |
| Equity-to-net-balance ratio | 15.5% | At least 17% | At least 12%, with a 14% coupon step-up threshold | Broken versus the bank, still above the bond package |
| Debt-to-collateral ratio | Series B 62.9%, Series C 71.8%, Series D 65% | Not relevant | Caps of 80% for Series B and 82.5% for Series C and D | The bonds still had collateral cushion |
That is the core split. In the bond market the company still looked inside the lines. Against the remaining bank commitment, it was already on the wrong side of the line and needed an explicit waiver. In financing-risk terms, that matters more than whether a particular bond series still has a few more points of cushion on paper.
Why The Bonds Still Look Relatively Calm
Note 18 is not rosy, but it is clearly calmer. The company explicitly says that as of December 31, 2025 it was in compliance with all financial covenants for Series B, C and D. Equity of NIS 181.2 million was above the NIS 130 million default threshold and also above the coupon step-up thresholds of NIS 140 million for Series B and C and NIS 155 million for Series D. The 15.5% equity-to-net-balance ratio was above both the 12% default floor and the 14% step-up floor.
There was still room on the project-collateral side as well. Debt-to-collateral stood at 62.9% for Series B, 71.8% for Series C and 65% for Series D, against caps of 80% and 82.5%. If those ratios are breached, the trust deeds also provide an automatic 90-business-day cure period. That is not immunity from trouble, but it is a mechanism that gives time in a way that a broken bank commitment requiring a waiver simply does not.
There is one important qualification here. Even inside the bond layer, this is not a story of full freedom. In March 2026 only half of Series D proceeds was transferred to the company, and the second half depends on a full building permit at Havatzelet HaSharon. If the permit is not received within six months of the deed date, the coupon rises by 0.125%. So even the relatively calm bonds still depend on an unfinished planning and financing milestone. But that is still a problem inside a structure that retains cushion. It is not the same kind of pressure as a bank covenant that already broke.
Why This Matters More Than Relative Bond Calm
Note 24 is where the argument gets decided. At year-end 2025 the company reported continuing negative operating cash flow of about NIS 69.9 million, a 12-month working-capital deficit of about NIS 71 million, and only about NIS 5.5 million of cash and cash equivalents. Management explains why it does not see a liquidity problem, but its own source list is telling: half of Series D proceeds, about NIS 15 million of unused credit lines, the ability to raise more debt, and expected project surpluses of about NIS 649 million, of which about NIS 415 million had already been pledged to issued bonds, including Series D.
The contractual maturity table in the same note sharpens the point even more. Because of uncertainty around the repayment dates of project loans, the company presents all of those loans inside the up-to-one-year bucket. That does not make the table a final amortization schedule, but it does show what the structure functionally depends on: up to one year, the company shows contractual cash flows of about NIS 637.5 million for bank and other credit, against only about NIS 17.7 million for bonds.
That is the number that explains why the bank waiver matters more than the relative calm in the bonds. Even if the bonds are still well inside their covenant package, the company is living through the interim period on a sequence of bank credit, institutional credit, extensions until permits, and eventual conversion into project finance. The bond layer is secured on pledged project surplus. The bank and institutional layer is the one that still has to keep giving time.
The post-balance-sheet events reinforce that reading. Note 26 and the March 29, 2026 immediate report explicitly say that the institutional credit facility for the Havatzelet HaSharon project was extended through June 30, 2026. That is not a secondary-market interpretation. It is a direct extension of the rope inside the land-financing layer. So the practical question is not whether Series D still sits below its debt-to-collateral cap. The practical question is whether the company keeps receiving waivers, extensions and refinancing until permits become full project finance and until projected surpluses become unencumbered cash.
What The Bonds Do Say, And What They Do Not
The bonds do say two constructive things. First, at year-end 2025 there was still covenant room in the public package. Second, the trust deeds are built around project collateral, cure mechanisms and relatively explicit triggers. That gives the bond market a more orderly language for reading the risk.
But the bonds do not say the company has passed its financing test. They do not erase the fact that the remaining bank commitment already needed a waiver. They do not turn half of Series D proceeds into open cash while the full Havatzelet HaSharon permit is still pending. And they do not change the fact that most of the coming year’s contractual picture still runs through bank and institutional credit.
Put differently, the relative calm in the bonds is real, but it is calm in only one layer. It is not a verdict on the whole capital structure.
What Needs To Happen Next
If this thesis is right, the next checkpoints are fairly clear:
- The bank waiver has to turn into a more durable fix, either through another amendment or through replacement of that financing layer.
- Havatzelet HaSharon has to reach a full permit, both to release the second half of Series D proceeds and to reduce dependence on land-financing bridges.
- The sequence of extensions in private credit has to turn into orderly project finance, otherwise the company will keep moving from one financing window to the next.
- Projected surpluses have to start becoming accessible cash that is not fully pledged, otherwise the calm in the bonds will remain mainly collateral calm rather than liquidity calm.
Conclusion
Current thesis: at year-end 2025 the bonds were still giving Ram Aderet time, but the remaining bank commitment was already asking for a waiver.
That is why the bank waiver matters more than the relative calm in the bonds. It touches the layer that finances the interim period, the land, and the move from permit to project finance. The bonds, by contrast, mainly show that there is still cushion inside the public package and that project surplus is still providing collateral.
The strongest counter-thesis is that this gap may close quickly: permits may arrive, Series D may release the second half of its proceeds, land bridges may convert into full project finance, and the bank waiver may prove to be a one-off event rather than a structural signal. That is possible. But as of year-end 2025 and late March 2026, what has already been proven is the opposite: when the company needed immediate financing flexibility, it received it from banks and lenders, not from the simple fact that the bonds were still inside covenant.
So anyone reading Ram Aderet only through the public bond series risks missing the real pressure point. The 2026 test is not whether the bonds look calm. The 2026 test is whether the private financing layer can keep holding until paper collateral starts turning into actual cash.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.